Cargando…

From discovery of RANKL to clinical application of anti-human RANKL antibody

Detalles Bibliográficos
Autores principales:	Yasuda, Hisataka, Furuya, Yuriko, Uchida, Kohji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332501/ http://dx.doi.org/10.1186/ar3588

Ejemplares similares

Regulation of RANKL signaling in arthritic bone destruction
por: Takayanagi, H
Publicado: (2003)

Stimulation of bone formation in cortical bone of the mice treated with a novel bone anabolic peptide with osteoclastogenesis inhibitory activity
por: Furuya, Yuriko, et al.
Publicado: (2012)

Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor
por: Coleman, RE
Publicado: (2009)

Individual and combining effects of anti-RANKL monoclonal antibody and teriparatide in ovariectomized mice
por: Tokuyama, Naoto, et al.
Publicado: (2015)

Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity
por: Furuya, Yuriko, et al.
Publicado: (2013)

RANKL expression in human T-lymphocytes requires cooperative signaling through the T-cell receptor and adhesion molecule CD2
por: Harvey, B P, et al.
Publicado: (2010)

Clinical development of anti-RANKL therapy
por: Schwarz, Edward M, et al.
Publicado: (2007)

Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis
por: Ozaki, Yuki, et al.
Publicado: (2017)

Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL
por: Jang, Yuria, et al.
Publicado: (2021)

The importance of cell surface RANKL in rheumatoid arthritis
por: Krystufkova, O, et al.
Publicado: (2005)

RANKL Expression in Periodontal Disease: Where Does RANKL Come from?
por: Chen, Bin, et al.
Publicado: (2014)

Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats
por: Lv, Dawei, et al.
Publicado: (2022)

The crucial role of osteocyte-derived RANKL in bone homeostasis
por: Nakashima, Tomoki, et al.
Publicado: (2012)

The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
por: Simatou, Aristofania, et al.
Publicado: (2020)

Effects of anti-mouse RANKL antibody on orthodontic tooth movement in mice
por: Yoshimatsu, Masako, et al.
Publicado: (2022)

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010)

Targeting RANKL in metastasis
por: Dougall, William C, et al.
Publicado: (2014)

Neutrophils are the source of IL-17 and RANKL in zymosan induced arthritis
por: Milanova, Viktoriya I, et al.
Publicado: (2012)

Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males
por: Findlay, David, et al.
Publicado: (2008)

Increased Bone Mass in Mice after Single Injection of Anti-receptor Activator of Nuclear Factor-κB Ligand-neutralizing Antibody: EVIDENCE FOR BONE ANABOLIC EFFECT OF PARATHYROID HORMONE IN MICE WITH FEW OSTEOCLASTS
por: Furuya, Yuriko, et al.
Publicado: (2011)

Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007)

Role of RANKL inhibition in osteoporosis
por: McClung, Michael
Publicado: (2007)

RANK–RANKL signalling in cancer
por: Renema, Nathalie, et al.
Publicado: (2016)

Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis
por: Erkhembaatar, Munkhsoyol, et al.
Publicado: (2015)

Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences
por: Heymann, Dominique
Publicado: (2012)

STAT3 is critical to promote inflammatory cytokines and RANKL expression in inflammatory arthritis
por: Miyamoto, Takeshi, et al.
Publicado: (2012)

Treg increases HepG2 cell growth by RANK-RANKL pathway
por: Ye, Yunbin, et al.
Publicado: (2014)

Sustained anti-osteoporotic action of risedronate compared to anti-RANKL antibody following discontinuation in ovariectomized mice
por: Omiya, Toshinobu, et al.
Publicado: (2020)

Mesenchymal Stromal Cell‐Seeded Biomimetic Scaffolds as a Factory of Soluble RANKL in Rankl‐Deficient Osteopetrosis
por: Menale, Ciro, et al.
Publicado: (2018)

RANKL immunisation inhibits prostate cancer metastasis by modulating EMT through a RANKL-dependent pathway
por: Park, Mineon, et al.
Publicado: (2021)

Applications of RNA structure analysis to retroviral packaging and anti-retroviral therapeutic discovery
por: Weeks, Kevin M, et al.
Publicado: (2011)

Is RANKL inhibition both anti-resorptive and anabolic in rheumatoid arthritis?
por: Sims, Natalie A., et al.
Publicado: (2015)

Anti-RANKL Inhibits Thymic Function and Causes DRONJ in Mice
por: Nakamura, Yusuke, et al.
Publicado: (2022)

Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity
por: Dougall, William C., et al.
Publicado: (2019)

Biological Effects of Anti-RANKL Antibody and Zoledronic Acid on Growth and Tooth Eruption in Growing Mice
por: Isawa, Motoki, et al.
Publicado: (2019)

A simple and robust reporter gene assay for measuring the bioactivity of anti-RANKL therapeutic antibodies
por: Yu, Chuanfei, et al.
Publicado: (2019)

Emerging Functions of RANKL in Lymphoid Tissues
por: Mueller, Christopher G., et al.
Publicado: (2012)

Mitf Induction by RANKL Is Critical for Osteoclastogenesis
por: Lu, Ssu-Yi, et al.
Publicado: (2010)

RANK/RANKL expression in prostate cancer
por: Ohtaka, Mari, et al.
Publicado: (2016)

The Roadmap of RANKL/RANK Pathway in Cancer
por: Casimiro, Sandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2qvbn14su34j1o0nk83cdp9a2n